Yikon Genomics
Latest round
- Series D
Last raised
- May 2021
Total raised
- $93M
Investors
- 11
About Yikon Genomics
Established in 2012 and based in Shanghai, China, Yikon Genomics operates as a gene testing platform that provides gene testing and therapy for fertility and tumor., Ltd., and have offices in Guangzhou and Wuhan. The company engages in the sales and production of gene testing and therapy for fertility and tumor. The company is committed to the development and application of single-cell whole-genome and transcriptome amplification sequencing technologies to provide precision medical testing services for reproductive health and tumor prevention and treatment. In the future, the company will promote product technology research and development, clinical trials, channel expansion, market promotion and clinical transformation in the full cycle of reproductive health and tumor screening and diagnosis and treatment.
Who invested in Yikon Genomics
11 investors across 3 rounds
See all investors in Yikon Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yikon Genomics
Who invested in Yikon Genomics?
Yikon Genomics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yikon Genomics raised?
Yikon Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Yikon Genomics last raise money?
Yikon Genomics's most recent round on record is a Series D, in May 2021.
What does Yikon Genomics do?
Established in 2012 and based in Shanghai, China, Yikon Genomics operates as a gene testing platform that provides gene testing and therapy for fertility and tumor.
Where is Yikon Genomics headquartered?
Yikon Genomics is headquartered in Shanghai, China.
Which VCs invest in companies like Yikon Genomics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yikon Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Yikon Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.